alexa

GET THE APP

MicroRNAs And Epigenetics In Alzheimer’s Disease: Study From The Whole Human Genome | 39042
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

MicroRNAs and epigenetics in Alzheimer’s disease: Study from the whole human genome

6th World Congress on Biotechnology

Debjani Roy1, Paulami Chatterjee1 and Nitin Rathi2

1Bose Institute, India 2University of South Florida, USA

ScientificTracks Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.C1.043

Abstract
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease throughout the world. Most of the clinical symptoms of AD appear at a very later stage, therefore, the identification of disease markers is essential which can help proper detection of AD at an earlier stage and slow down its progression. Small non-coding RNAs, microRNAs (miRNAs), are modulators of gene expressions and play important roles in cellular processes. Recent studies implicate certain miRNAs in the pathogenesis of AD. Epigenetic markers such as DNA methylation and histone modification around promoter regions modify chromatin structure and regulate expression of downstream genes. Epigenetic studies have also revealed that miRNAs are directly regulated by DNA methylation and histone modification at their promoters as well. In this work, we have performed a genome wide study to reveal the distribution of AD related proteins (AD_R) and proteins previously not known to be associated with AD (AD_UR) from the human genome. We have constructed regulatory networks involving genes, transcription factors and miRNAs. Several network motifs namely feed forward loop (FFL), feed-back loop (FBL) and single input module (SIM) were studied from the regulatory networks. We have identified the epigenetic modification patterns of regulators of these network motifs. Our study also revealed the long non-coding RNA and other non-coding RNA mediated regulations in AD. AD biomarkers and epigenetic modifications identified in our study will provide insight into new AD therapeutic targets.
Biography

Debjani Roy has completed her PhD in Computational Biology from New York University, USA. She is currently an Assistant Professor at Biophysics Department, Bose Institute, Kolkata. Her research interests include computational systems biology, drug repositioning and structural bioinformatics. She has so far published more than 30 papers in reputed journals and has presented her work in many national and international conferences.

Email: [email protected] [email protected]

Top